57 related articles for article (PubMed ID: 33356997)
1. The Prevalence, Associated Factors for Lung Metastases Development and Prognosis in Ovarian Serous Cancer Based on SEER Database.
Cao C; Yang X
Technol Cancer Res Treat; 2020; 19():1533033820983801. PubMed ID: 33356997
[TBL] [Abstract][Full Text] [Related]
2. The Prevalence and associated Factors for Liver Metastases, Development and Prognosis in newly diagnosed Epithelial Ovarian Cancer: A large Population-Based Study from the SEER Database.
Hussain I; Xu J; Deng K; Noor-Ul-Amin ; Wang C; Huang Y; Li S; Li K
J Cancer; 2020; 11(16):4861-4869. PubMed ID: 32626533
[No Abstract] [Full Text] [Related]
3. Exploration and prognostic analysis of two types of high-risk ovarian cancers: clear cell vs. serous carcinoma: a population-based study.
Liu T; Gao Y; Li S; Xu S
J Ovarian Res; 2024 Jun; 17(1):119. PubMed ID: 38824600
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive prognostic analysis of cause-specific mortality in patients with ovarian serous cystadenocarcinoma using a competing-risks model: a case study of the SEER database.
Chong SM; Li YJ; He Y; Chokkakula S; Ming WK; Leong NC; Zhao QQ; Chen WH; Huang CD; Deng LH; Lyu J
Eur Rev Med Pharmacol Sci; 2023 Nov; 27(22):11143-11155. PubMed ID: 38039046
[TBL] [Abstract][Full Text] [Related]
5. Lung and bone metastases patterns in limb osteosarcoma: Surgical treatment of primary site improves overall survival.
Liu B; Tang L; Peng N; Wang L
Medicine (Baltimore); 2023 Oct; 102(42):e35671. PubMed ID: 37861481
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and prognosis of bone metastases in common solid cancers at initial diagnosis: a population-based study.
Zhang J; Cai D; Hong S
BMJ Open; 2023 Oct; 13(10):e069908. PubMed ID: 37865405
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Synchronous Lung Metastasis in Squamous Cell Carcinoma of Hypopharynx.
Li Y; Hu C
Ear Nose Throat J; 2023 Nov; ():1455613231212052. PubMed ID: 37991192
[No Abstract] [Full Text] [Related]
8. Incidence and prognosis of liver metastasis at diagnosis: a pan-cancer population-based study.
Wang S; Feng Y; Swinnen J; Oyen R; Li Y; Ni Y
Am J Cancer Res; 2020; 10(5):1477-1517. PubMed ID: 32509393
[TBL] [Abstract][Full Text] [Related]
9. Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo.
Qi ZY; Wang F; Yue YY; Guo XW; Guo RM; Li HL; Xu YY
J Ovarian Res; 2023 Aug; 16(1):174. PubMed ID: 37626400
[No Abstract] [Full Text] [Related]
10. Incidence of and risk factors associated with lung metastases in newly diagnosed epithelial ovarian cancer with a look on prognosis after diagnosis: a population-based cohort study of the SEER database.
Xu J; Hussain I; Wang L; Deng K; Zhao L; Zhou K; Zhang L; Xu Z; Li K
Arch Gynecol Obstet; 2021 Oct; 304(4):1007-1020. PubMed ID: 33635405
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
Wang B; Wang S; Ren W
BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
[TBL] [Abstract][Full Text] [Related]
12. A Practical Nomogram to Predict Early Death in Advanced Epithelial Ovarian Cancer.
Song Z; Zhou Y; Bai X; Zhang D
Front Oncol; 2021; 11():655826. PubMed ID: 33816311
[No Abstract] [Full Text] [Related]
13. A prognostic nomogram for women with primary ovarian signet-ring cell carcinoma.
Wang X; Ke X; Min J
Ann Transl Med; 2021 Apr; 9(7):525. PubMed ID: 33987223
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of nomograms for epithelial ovarian cancer: a SEER population-based, real-world study.
Wang R; Xie G; Shang L; Qi C; Yang L; Huang L; Li D; Yang W
Future Oncol; 2021 Mar; 17(8):893-906. PubMed ID: 33533669
[No Abstract] [Full Text] [Related]
15. Clinical characteristics and prognostic factors of stage IC ovarian clear cell carcinoma: a Surveillance, Epidemiology, and End Results (SEER) analysis.
Chen Q; Wang S; Lang JH
Arch Gynecol Obstet; 2021 Aug; 304(2):521-529. PubMed ID: 33543331
[TBL] [Abstract][Full Text] [Related]
16. A nomogram to predict the cancer-specific survival of stage II-IV Epithelial ovarian cancer after bulking surgery and chemotherapy.
Zhao L; Yu P; Zhang L
Cancer Med; 2021 Jul; 10(13):4344-4355. PubMed ID: 34057318
[TBL] [Abstract][Full Text] [Related]
17. A Novel Clinical Nomogram for Predicting Cancer-Specific Survival in Adult Patients After Primary Surgery for Epithelial Ovarian Cancer: A Real-World Analysis Based on the Surveillance, Epidemiology, and End Results Database and External Validation in a Tertiary Center.
Li X; Xu H; Yan L; Gao J; Zhu L
Front Oncol; 2021; 11():670644. PubMed ID: 33959514
[TBL] [Abstract][Full Text] [Related]
18. Effect of different treatment modalities on ovarian cancer patients with liver metastases: A retrospective cohort study based on SEER.
Li N; Jin S; Wu J; Ji H; Du C; Liu B
PLoS One; 2024; 19(4):e0299504. PubMed ID: 38635517
[TBL] [Abstract][Full Text] [Related]
19. The Importance of Marital Status in the Morbidity and Prognosis of Lung Metastasis in Newly Diagnosed Ovarian Cancer.
Qian L; Chen Y; Peng M; Xia Y; Zhou T; Hong J; Ding S
J Cancer; 2023; 14(6):1024-1038. PubMed ID: 37151400
[No Abstract] [Full Text] [Related]
20. A Machine Learning Approach Using XGBoost Predicts Lung Metastasis in Patients with Ovarian Cancer.
Yuan Y; Wang R; Luo M; Zhang Y; Guo F; Bai G; Yang Y; JingZhao
Biomed Res Int; 2022; 2022():8501819. PubMed ID: 36277898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
